|
JP2008512364A
(ja)
*
|
2004-09-06 |
2008-04-24 |
エフ．ホフマン−ラ ロシュ アーゲー |
４−アミノメチルベンズアミジン誘導体及び第ＶＩＩａ因子阻害剤としてのその使用
|
|
US20100234438A1
(en)
*
|
2006-06-20 |
2010-09-16 |
Leifeng Cheng |
Therapeutic agents
|
|
GB0622569D0
(en)
*
|
2006-11-11 |
2006-12-20 |
7Tm Pharma As |
Cannabinoid receptor modulators
|
|
NZ578063A
(en)
*
|
2006-12-18 |
2011-09-30 |
7Tm Pharma As |
Cannabinoid CB1 receptor modulators
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US8133904B2
(en)
*
|
2007-09-07 |
2012-03-13 |
Jenrin Discovery, Inc. |
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
|
|
US7655685B2
(en)
*
|
2007-11-02 |
2010-02-02 |
Jenrin Discovery, Inc. |
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
|
|
RU2392943C2
(ru)
*
|
2007-11-22 |
2010-06-27 |
Людмила Александровна Орлова |
Способ разгрузочно-диетической терапии
|
|
CA2708706A1
(en)
*
|
2007-12-10 |
2009-06-18 |
7Tm Pharma A/S |
Cannabinoid receptor modulators
|
|
AR069700A1
(es)
*
|
2007-12-18 |
2010-02-10 |
Sanofi Aventis |
Derivados de azetidina,composiciones farmaceuticas que los comprenden, metodo de preparacion, intermediarios de sintesis,y usos de los mismos en el tratamiento o prevencion de trastornos psiquiatricos , del sistema inmune y gastrointestinales, entre otros.
|
|
WO2009097995A1
(de)
*
|
2008-02-07 |
2009-08-13 |
Sanofi-Aventis |
Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8895776B2
(en)
*
|
2008-03-18 |
2014-11-25 |
Arena Pharmaceuticals, Inc. |
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
|
|
ES2349838B1
(es)
*
|
2009-05-04 |
2011-11-15 |
Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanitaria (Fundacion Im |
Derivados de pirazol bivalentes como inhibidores de ingesta
|
|
DE102009036604A1
(de)
|
2009-07-30 |
2011-02-03 |
Aicuris Gmbh & Co. Kg |
Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung
|
|
CN102260246B
(zh)
*
|
2010-05-28 |
2014-08-13 |
范如霖 |
低毒性cb1受体抑制剂、其制备方法及其在制备戒毒、减肥或治疗糖尿病药物中的应用
|
|
EP2642856B1
(en)
*
|
2010-11-24 |
2017-07-19 |
The Ohio State University Research Foundation |
Integrin-linked kinase inhibitors
|
|
CN102603713B
(zh)
*
|
2011-01-25 |
2014-05-14 |
范如霖 |
手性cb1受体抑制剂、制备方法及其医学用途
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120054A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120055A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
CN102212058B
(zh)
*
|
2011-04-14 |
2014-04-02 |
范如霖 |
“单一的复合药”：手性含氮杂环酯、合成法及其在制备低毒性cb1受体抑制剂中的应用
|
|
CN103554025B
(zh)
*
|
2011-05-12 |
2016-08-10 |
范如霖 |
3-砒唑羧酸酰胺类化合物、其制备方法及其在制备作为cb1受体抑制剂药物中的应用
|
|
CN102250006B
(zh)
*
|
2011-05-12 |
2014-03-05 |
范如霖 |
3-吡唑羧酸酰胺类化合物、其制备方法及其在制备作为cb1受体抑制剂药物中的应用
|
|
US9133128B2
(en)
|
2011-06-17 |
2015-09-15 |
Research Triangle Institute |
Pyrazole derivatives as cannabinoid receptor 1 antagonists
|
|
WO2013014204A2
(en)
|
2011-07-26 |
2013-01-31 |
Sanofi |
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
|
|
CN103459383B
(zh)
|
2011-09-30 |
2016-06-22 |
财团法人国家卫生研究院 |
吡唑类化合物
|
|
BR102012017421A2
(pt)
|
2012-07-13 |
2015-04-14 |
Proteimax Biotecnolgia Ltda |
Peptídeo, composicão farmacêutica, ligante de receptor cb, metodo para modular a funcao de receptor cb, uso, método para o tratamento de obesidade, e, método para promover a redução de peso estetica em um indivíduo
|
|
WO2015188073A1
(en)
|
2014-06-06 |
2015-12-10 |
Research Triangle Institute |
Apelin receptor (apj) agonists and uses thereof
|
|
AU2016366310C1
(en)
|
2015-12-09 |
2021-09-09 |
Research Triangle Institute |
Improved apelin receptor (APJ) agonists and uses thereof
|
|
EP3279197A1
(en)
*
|
2016-08-03 |
2018-02-07 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Diagnosis, treatment and prevention of neurotensin receptor-related conditions
|
|
ES3032633T3
(en)
*
|
2016-10-12 |
2025-07-22 |
Res Triangle Inst |
Heterocyclic apelin receptor (apj) agonists and uses thereof
|
|
WO2018068120A1
(pt)
*
|
2016-10-13 |
2018-04-19 |
Proteimax Biotecnologia Ltda |
Uso de composto, intermediário de síntese, composição farmacêutica e método terapêutico neuromodulador
|
|
IL268997B2
(en)
|
2017-03-01 |
2023-09-01 |
Arena Pharm Inc |
Preparations containing pgi2 receptor agonists and processes for their preparation
|
|
KR101974414B1
(ko)
*
|
2017-09-12 |
2019-05-02 |
주식회사 티에스디라이프사이언스 |
1h-피라졸-3-아마이드계 화합물 유도체를 포함하는 섬유증 예방 또는 치료용 조성물
|
|
AU2019213694B2
(en)
*
|
2018-01-30 |
2023-04-06 |
Pi Industries Ltd. |
Novel anthranilamides, their use as insecticide and processes for preparing the same.
|
|
US10897925B2
(en)
|
2018-07-27 |
2021-01-26 |
Joseph Pandolfino |
Articles and formulations for smoking products and vaporizers
|
|
US20200035118A1
(en)
|
2018-07-27 |
2020-01-30 |
Joseph Pandolfino |
Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
|
|
AU2019387370A1
(en)
|
2018-11-30 |
2021-06-10 |
Nuvation Bio Inc. |
Pyrrole and pyrazole compounds and methods of use thereof
|
|
IL317596A
(en)
*
|
2019-01-15 |
2025-02-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Peripheral CB1 receptor inhibitors
|
|
KR20220054391A
(ko)
|
2019-08-29 |
2022-05-02 |
리서치 트라이앵글 인스티튜트 |
아펠린 수용체 작용제에 대한 방법 및 용도
|
|
WO2022164239A1
(ko)
*
|
2021-01-28 |
2022-08-04 |
주식회사 파미노젠 |
피라졸-카르복스아미드 유도체 화합물 및 이의 용도
|
|
WO2024092205A1
(en)
*
|
2022-10-27 |
2024-05-02 |
The Trustees Of Indiana University |
Inhibition of ship1 as a therapeutic strategy for the treatment of alzheimer's disease
|
|
WO2025175318A2
(en)
*
|
2024-02-18 |
2025-08-21 |
Luminous Mind Inc. |
Pharmacotherapies for improving treatment adherence after discontinuation of incretin-based therapies
|
|
WO2025199092A1
(en)
*
|
2024-03-20 |
2025-09-25 |
The Trustees Of Indiana University |
Ship1 modulators and methods of treatment and uses thereof
|